Rankings
▼
Calendar
HOTH Q4 2018 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOTH
Hoth Therapeutics, Inc.
$15M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$28,252
Operating Income
-$624,044
Net Income
-$480,044
EPS (Diluted)
$-1.27
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$455,062
Free Cash Flow
-$455,062
Stock-Based Comp.
$4,963
Balance Sheet
Total Assets
$503,916
Total Liabilities
$348,951
Stockholders' Equity
$154,965
Cash & Equivalents
$282,621
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$28,252
$0
—
Operating Income
-$624,044
-$1M
+50.2%
Net Income
-$480,044
-$1M
+63.8%
← FY 2018
All Quarters
Q1 2019 →